ACUTE MYELOID LEUKEMIA (AML)
Clinical trials for ACUTE MYELOID LEUKEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough blood cancers: modified transplant aims to beat disease
Disease control OngoingThis study is for children and young adults (up to age 21) with high-risk blood cancers like leukemia and lymphoma. It tests a modified blood cell transplant from a partially matched family donor. The donor cells are processed in a lab to remove certain immune cells that can caus…
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
New hope for tough blood cancers: drug added to transplant process
Disease control OngoingThis study is testing the safety of adding a drug called venetoclax to the standard treatment given before a bone marrow transplant for people with high-risk blood cancers like AML and MDS. It also tests giving venetoclax with other drugs after the transplant to try to prevent th…
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Personalized drug approach aims to make cancer transplants safer
Disease control OngoingThis study is testing if adjusting the dose of a drug called rabbit ATG based on a patient's individual needs can help the immune system recover faster after a stem cell transplant. The goal is to reduce serious side effects and improve survival for children and adults with certa…
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for frail AML patients: testing a gentler, targeted drug cocktail
Disease control OngoingThis study is testing a new combination of three oral and injectable drugs (gilteritinib, venetoclax, and azacitidine) for adults newly diagnosed with a fast-growing type of acute myeloid leukemia (AML) who are too old or have other health problems that make standard chemotherapy…
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Oral pill aims to keep deadly blood cancer at bay
Disease control OngoingThis study is looking at how well an oral medication called ONUREG (azacitidine) works in real-world settings to help keep acute myeloid leukemia (AML) from coming back. It involves 44 adults in Hong Kong who have achieved remission after initial chemotherapy but cannot or choose…
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC